Diabetes Drug Shows Benefit in Parkinson's Disease

Phase II study of GLP-1 drug lixisenatide meets primary endpoint

Related Keywords

France ,David Standaert ,Olivier Rascol ,Judy George ,Movement Disorder Society ,University Of Toulouse ,University Of Alabama At Birmingham ,Movement Disorder Society Unified Parkinson ,Disease Rating Scale ,New England Journalof ,Medpage Today ,England Journal ,Englj Med ,